×
About 273 results

ALLMedicine™ Hypermagnesemia Center

Research & Reviews  96 results

Mechanisms of paracellular transport of magnesium in intestinal and renal epithelia.
https://doi.org/10.1111/nyas.14953
Annals of the New York Academy of Sciences; Houillier P, Lievre L et. al.

Jan 10th, 2023 - Magnesium is the fourth most abundant cation in the body. It plays a critical role in many biological processes, including the process of energy release. Paracellular transport of magnesium is mandatory for magnesium homeostasis. In addition to in...

The association of serum magnesium with infection in new-onset systemic lupus erythemat...
https://doi.org/10.1177/09612033221149884
Lupus Yang W, Lian X et. al.

Jan 4th, 2023 - To assess the association of serum magnesium with infection in new-onset systemic lupus erythematosus (SLE) patients. We conducted a single-center retrospective cohort study of new-onset SLE patients from 2012 to 2021. The hospitalized SLE patient...

Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observat...
https://doi.org/10.1186/s12871-022-01903-2
BMC Anesthesiology; Tonai K, Katayama S et. al.

Nov 25th, 2022 - Hypomagnesemia reportedly has significant associations with poor clinical outcomes such as increased mortality and septic shock in patients with sepsis. Although the mechanism underlying these outcomes mostly remains unclear, some experimental dat...

Magnesium in chronic haemodialysis (MAGIC-HD): a study protocol for a randomised contro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680141
BMJ Open; Leenders NHJ, Douma CE et. al.

Nov 22nd, 2022 - People treated with haemodialysis are at increased risk for all-cause and cardiovascular mortality. Plasma magnesium concentration has been inversely associated with these risks. Therefore, plasma magnesium may be a new modifiable risk factor and ...

Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease
https://clinicaltrials.gov/ct2/show/NCT02542319

Sep 6th, 2022 - Chronic kidney disease (CKD) is associated with increase cardiovascular morbidity and mortality independent of traditional cardiovascular risk factors due to increased vascular calcification. Epidemiological and experimental data suggest that hype...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  4 results

Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease
https://clinicaltrials.gov/ct2/show/NCT02542319

Sep 6th, 2022 - Chronic kidney disease (CKD) is associated with increase cardiovascular morbidity and mortality independent of traditional cardiovascular risk factors due to increased vascular calcification. Epidemiological and experimental data suggest that hype...

Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes
https://clinicaltrials.gov/ct2/show/NCT04256369

Feb 3rd, 2022 - Methods Study design and centres This is a prospective, cohort, multi-centre study, to be conducted at King Faisal Specialist Hospital and Research Centre, (KFSH & RC), Riyadh. The study has been approved by KFSH&RC Office of Research Affairs repr...

Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease
https://clinicaltrials.gov/ct2/show/NCT02216877

Apr 28th, 2015 - Chronic kidney disease (CKD) is associated with increase cardiovascular morbidity and mortality independent of traditional cardiovascular risk factors due to increased vascular calcification. Epidemiological and experimental data suggest that hype...

Magnesium Replacement Therapy to Prevent Acute Renal Failure in Critically Ill Patients
https://clinicaltrials.gov/ct2/show/NCT01700998

Nov 4th, 2014 - Acute renal failure (ARF) is a serious and common complication in hospitalized patients, occurring in more than 25% of intensive care unit (ICU) patients. Hypomagnesemia is a common disorder, occurring in approximately 12% of hospitalized patients...

see more →

News  6 results

First FDA Approval for Prevention of Acute Graft-vs-Host Disease
https://www.medpagetoday.com/hematologyoncology/othercancers/96220

Dec 15th, 2021 - The FDA granted a first-ever approval of a treatment to prevent acute graft-versus-host disease (aGVHD) in patients undergoing bone marrow or stem-cell transplantation. The approval allows use of abatacept (Orencia) in combination with certain imm...

Preoperative Immunotherapy Sends Positive Signals in 2 NSCLC Studies
https://www.onclive.com/view/preoperative-immunotherapy-sends-positive-signals-in-2-nsclc-studies

Dec 20th, 2020 - David J. Kwiatkowski, MD, PhD Neoadjuvant immunotherapy demonstrated substantial activity with a favorable toxicity profile in findings from 2 studies of patients with operable early-stage non—small cell lung cancer (NSCLC) reported at the 2019 A...

FDA warns about magnesium sulfate effects on newborns
https://www.mdedge.com/obgyn/article/58987/womens-health/fda-warns-about-magnesium-sulfate-effects-newborns
Elizabeth Mechcatie

May 31st, 2013 - Magnesium sulfate should not be used for more than 5-7 days in pregnant women in preterm labor, because in utero exposure may lead to hypocalcemia and an increased risk of osteopenia and bone fractures in newborns, the Food and Drug Administration.

FDA Limits Magnesium to Prevent Preterm Labor
https://www.medpagetoday.com/obgyn/pregnancy/39486

May 30th, 2013 - The FDA today advised clinicians not to give pregnant women magnesium sulfate to prevent preterm labor for more than 5 to 7 days because it may harm developing fetal bones. Longer off-label administration of magnesium for tocolysis, which is appro...

CKD and Low Magnesium: Pay Attention
https://www.medscape.com/viewarticle/778787

Feb 6th, 2013 - The Study and Background The Study Khan AM, Lubitz SA, Sullivan LM, et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2013;127:33-38. Background Nephrologists do not fr...

see more →